Applications published 5 December 2007

Potato proteinase inhibitor II exhibits activity in elevating fasting plasma cholecystokinin concentrations
Kemin Foods 1861065*

• Stable mixed emulsions comprising semisolid dispersions of at least two discrete and distinctly different particle size ranges
Combe Inc 1861067*

• Nanocells for diagnosis and treatment of diseases and disorders
Massachusetts Institute of Technology 1861072*

• Process for the production of calcium compsns in a continuous fluidised bed
Nycomed Pharma 1861073*

• Taste masked dosage form containing roflumilast
Nycomed 1861074*

• Coated granular formulations
Truffini & Regge" Farmaceutici 1861075*

• A transdermal topical compsn and its uses
Transphase 1861076*

• Non-invasive method for prevention and treatment of cancer
Medical Research 1861077*

• A capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
Kalamazoo Holdings 1861078*

• Arylsulphonyl benzyl ethers and 5-HT2A antagonists
Merck Sharp & Dohme 1861079*

• Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of muscular dystrophies
Santhera Pharmaceuticals (Schweiz) 1861080*

• Ophthalmic uses of S1P receptor modulators
Novartis 1861081*

• A topical compsn and its uses
Transphase 1861082*

• Compsn based on an avermectin and azelaic acid in particular for treating rosacea
Galderma 1861083*

• Improved formulations of fenodibrate containing methol or PEG/poloxamer
Teva Pharmaceutical Industries 1861084*

• Antiviral compsns and methods of use
3M Innovative Properties 1861085*

• Anti-proliferative combination therapy comprising satraplatin or JM118 and a taxane
GPC Biotech 1861086*

• Treatment with statin and omega-3 fatty acids and a combination product thereof
Reliant Pharmaceuticals 1861087*

• Medicament and treatment for herpes simplex
Sharma, Anant 1861088*

• Oral modified release formulations containing 8-prenylnaringenin for continuous oestrogen support
Kairosmed 1861089*

• Anti-inflammatory modalities
Novogen Research 1861090*

• Compounds having lipid lowering properties
Vital Health Sciences 1861091*

• Potassium channel opener having benzofuroindole skeleton
Anygen 1861092*

• Organic nitric oxide enhancing salts of angiotensin II antagonists, compsns and methods of use
Nitromed 1861093*

• Histone deacetylase inhibitors sensitise cancer cells to epidermal growth factor inhibitors
The Board of Regents of the University of Colorado 1861094*

• Derivatives of imidazo(1,2-A)pyridine useful as medicaments for treating gastrointestinal diseases
Glaxo Group 1861095*

• Use of opioid antagonists to attenuate endothelial cell proliferation and migration
The University of Chicago 1861096*

• Mitotic kinesin inhibitors
Merck & Co 1861097*

• Anti-inflammatory compounds
Novartis 1861098*

• Combination of a steroid sulphatase inhibitor and an ascomycin
Novartis 1861099*

• 3, IIb-cis-dihydrotetrabenzine for the treatment of a proliferative disease or an inflammation
Cambridge Laboratories (Ireland) 1861100*

• Use of 2-anilino-3,4-dihydro-quinazolines as 5HT5A receptor antagonists
F Hoffmann-La Roche 1861102*

• Compsn comprising ocaperidone
Janssen Pharmaceutica 1861103*

• Improved gacyclidine formulations
Neurosystec 1861104*

• Process for the preparation of galanthamine hydrobromide
Indena 1861105*

• Combination therapy for topical application in the treatment of age-related macular degeneration and ocular hypertension
Nascent Pharmaceuticals 1861106*

• Treatment of amyotrophic lateral sclerosis with norethindrone and analogues
Alsgen 1861107*

• Antimicrobial compounds
University of Strathclyde 1861108*

• Carotenoids, carotenoid analogues, or carotenoid derivatives for the treatment of proliferative disorders
Cardax Pharmaceuticals 1861109*

• Antibiotic combinations for providing total solutions to the treatment of infections
Venus Remedies 1861110*

• Methods and compsns for increasing the safety and efficacy of albumin-binding drugs
New Century Pharmaceuticals 1861111*

• Compsns and methods for topical application and transdermal delivery of botulinum toxins
Revance Therapeutics 1861112*

• Use of an onion extract for making a compsn to control weight gain
Scalime Nutrition 1861113*

• Compsns comprising modulators of G-protein-coupled receptor for treatment of macular degeneration
Potentia Pharmaceuticals 1861114*

• Semi-synthetic glycopeptides with antibiotic activity
Novartis Vaccines and Diagnostics 1861115*

• VEGF antagonist formulations
Regeneron Pharmaceuticals 1861116*

• Immunologically active compsns
Galen Bio 1861117*

• Identification of surface-associated antigens for tumour diagnosis and therapy
Ganymed Pharmaceuticals 1861118*

• Methods of treating or preventing a disease, disorder or condition associated with a viral infection
Barros Research Institute 1861119*

• Use of an influenza virus and an oil-in-water emulsion adjuvant to induce CD4 T-cell and/or improved B-memory cell response
GlaxoSmithKline Biologicals 1861120*

• HIV vaccine compsn
Variation Biotechnologies 1861121*

• Compsn
GlaxoSmithKline Biologicals 1861122*

• Synergistic effect of TGF-beta blockade and immunogenic agents on tumours
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services 1861123*

• Production of bioactive glycoproteins from inactive starting materials by conjugation with hydroxyalkylstarch
Fresenius Kabi Deutschland 1861124*

• Conjugation of an HGH moiety and PEG derivatives
Nektar Therapeutics 1861125*

• Treatment of protein degradation disorders
The President and Fellows of Harvard College; Dana-Farber Cancer Institute 1861126*

• Chelators for radioactively labelled conjugates comprising a stabilising sidechain
Bayer Schering Pharma 1861127*

• X
• LinkedIn

• Companies:
• Kemin

See more